HT
CLBT icon

Headlands Technologies’s Cellebrite CLBT Stock Holding History

Headlands Technologies’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-23,138
Closed -$319K – 761
2026
Q1 		$319K Buy
+23,138
New +$349K 0.04% 483

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Headlands Technologies's CLBT Position: Q2 2026 in Review

Headlands Technologies sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 23,138 shares — an estimated $319K sold.

Headlands Technologies first reported a position in CLBT in Q1 2026 and held it in 1 quarter. The position peaked at $319K in Q1 2026. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Headlands Technologies reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • Headlands Technologies sold 23,138 Cellebrite shares in Q2 2026, an estimated $319K.
  • Headlands Technologies first reported a position in Cellebrite in Q1 2026 and held it in 1 quarter.
  • Headlands Technologies's Cellebrite position peaked at $319K in Q1 2026.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.